Leveraging conformational ensembles in allosteric drug discovery

Area of Science:

• Biochemistry and Molecular Biology
• Pharmacology
• Structural Biology

Background:

• Signaling proteins like Ras, mTOR, and EGFR exist as dynamic conformational ensembles within biomolecular condensates.
• Traditional drug discovery models, such as the induced fit model, viewed proteins as rigid structures, limiting therapeutic development.
• These dynamic ensembles are critical for allosteric drug discovery and action.

Purpose of the Study:

• To review the limitations of traditional protein models in drug discovery.
• To highlight how understanding dynamic conformational ensembles enhances allosteric drug design.
• To discuss the role of ensemble-based approaches in developing future therapeutics.

Main Methods:

• Review of existing literature and research findings.
• Analysis of molecular dynamics simulations of oncogenic protein mutants.
• Experimental validation of transiently existing protein pockets and exosites.

Main Results:

• Heterogeneous dynamic ensembles of signaling proteins have been revealed through advanced simulations and experiments.
• Targetable cryptic pockets and cooperative exosites, transiently existing within these ensembles, have been identified.
• Leveraging conformational ensembles offers improved strategies for allosteric drug design.

Conclusions:

• Shifting from rigid protein models to dynamic conformational ensembles revolutionizes allosteric drug discovery.
• Ensemble-based approaches provide a more effective strategy for developing novel therapeutics.
• Understanding protein dynamics in biomolecular condensates is key for future drug development.